Pirepemat fumarate
Modify Date: 2025-08-25 07:30:27
Pirepemat fumarate structure
|
Common Name | Pirepemat fumarate | ||
|---|---|---|---|---|
| CAS Number | 2251806-70-7 | Molecular Weight | 329.30 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C15H17F2NO5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Pirepemat fumaratePirepemat (IRL752) fumarate is a corticalpreferring catecholamine- and cognition-promoting agent. Pirepemat fumarate is used for the study of Parkinson's disease[1][2]. |
| Name | Pirepemat fumarate |
|---|
| Description | Pirepemat (IRL752) fumarate is a corticalpreferring catecholamine- and cognition-promoting agent. Pirepemat fumarate is used for the study of Parkinson's disease[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | IRL752 fumarate displays its highest in vitro affinities for 5-HT and NA-related targets[2]. |
| In Vivo | IRL752 (3.7-100 µmol/kg, s.c.) fumarate has no significant effect on acute hyper-dopaminergic or hypo-glutamatergic motor responses, but reverses deficits resulting from hypomonoaminergic function[2]. Animal Model: Normal rats[2] Dosage: 3.7-100 µmol/kg Administration: S.c., 30 min prior to testing Result: Induced dose-dependent and regio-selective alterations in brain monoamine transmission indices and gene expression. |
| References |
| Molecular Formula | C15H17F2NO5 |
|---|---|
| Molecular Weight | 329.30 |